|Day Low/High||5.10 / 5.31|
|52 Wk Low/High||3.02 / 8.40|
Canopy Growth's smoking engine won't necessarily ensure smooth sailing for Constellation.
I'd be most interested in buying this name after a cap raise which I expect in the first quarter of 2019.
An early look at the market shows supply is finding it tough to keep up with demand.
A tie-up between the two could mark the first major U.S. firm to establish a line of CBD drinks.
Hexo is pursuing joint ventures in cosmetics, health care, candy, edibles, and vape companies.
The Nasdaq-listed provider of medical marijuana will compete with other firms as Canada opens itself to general adult use of marijuana this fall.